| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 2290- | Ba, | Research Progress of Scutellaria baicalensis in the Treatment of Gastrointestinal Cancer |
| - | Review, | GI, | NA |
| 5542- | BBM, | Pharmacological profiling of a berbamine derivative for lymphoma treatment |
| - | vitro+vivo, | lymphoma, | NA |
| 5543- | BBM, | Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo |
| - | in-vivo, | Lung, | B16-F10 | - | vitro+vivo, | Lung, | A549 | - | in-vitro, | BC, | MDA-MB-231 |
| 5550- | BBM, | docx, | Chit, | Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities |
| - | in-vivo, | Var, | NA |
| 2023- | BBR, | Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing Factor |
| - | in-vitro, | Colon, | NA | - | in-vitro, | Nor, | YAMC |
| 2022- | BBR, | GoldNP, | Rad, | Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition |
| - | in-vitro, | Liver, | SMMC-7721 cell | - | in-vitro, | Nor, | HL7702 |
| 2021- | BBR, | Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways |
| - | Review, | NA, | NA |
| 1405- | BBR, | Chit, | Chitosan/alginate nanogel potentiate berberine uptake and enhance oxidative stress mediated apoptotic cell death in HepG2 cells |
| - | in-vitro, | Liver, | HepG2 |
| 2678- | BBR, | Berberine as a Potential Agent for the Treatment of Colorectal Cancer |
| - | Review, | CRC, | NA |
| 2670- | BBR, | Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases |
| - | Review, | Var, | NA |
| - | in-vivo, | Diabetic, | NA |
| 2672- | BBR, | The anti-aging mechanism of Berberine associated with metabolic control |
| - | Review, | Var, | NA |
| 2673- | BBR, | Therapeutic potential and recent delivery systems of berberine: A wonder molecule |
| - | Review, | Var, | NA |
| 2674- | BBR, | Berberine: A novel therapeutic strategy for cancer |
| - | Review, | Var, | NA | - | Review, | IBD, | NA |
| 3678- | BBR, | Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model |
| - | Review, | AD, | NA |
| 3680- | BBR, | Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway |
| - | in-vivo, | AD, | NA |
| 5545- | BBR, | Improving the oral bioavailability of berberine: A crystal engineering approach |
| - | in-vivo, | Nor, | NA |
| 5179- | BBR, | Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy |
| - | Review, | Var, | NA |
| 5642- | BCA, | Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo |
| - | vitro+vivo, | Nor, | NA |
| 5640- | BCA, | Improved effectiveness of biochanin A as a P-gp inhibitor in solid dispersion |
| - | in-vitro, | Nor, | NA |
| 5631- | BCA, | Perspectives Regarding the Role of Biochanin A in Humans |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5632- | BCA, | Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats |
| - | in-vivo, | Var, | NA |
| 5633- | BCA, | Mechanisms Behind the Pharmacological Application of Biochanin-A: A review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5634- | BCA, | Molecular Mechanisms of Biochanin A in AML Cells: Apoptosis Induction and Pathway-Specific Regulation in U937 and THP-1 |
| - | in-vitro, | AML, | U937 | - | in-vitro, | AML, | THP1 |
| 5591- | BetA, | Advances and challenges in betulinic acid therapeutics and delivery systems for breast cancer prevention and treatment |
| - | Review, | BC, | NA |
| 5589- | BetA, | Advancements in Betulinic Acid-Loaded Nanoformulations for Enhanced Anti-Tumor Therapy |
| - | Review, | Var, | NA |
| 5588- | BetA, | Therapeutic applications of betulinic acid nanoformulations |
| - | Review, | Var, | NA |
| 2731- | BetA, | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
| - | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 2735- | BetA, | Betulinic acid as apoptosis activator: Molecular mechanisms, mathematical modeling and chemical modifications |
| - | Review, | Var, | NA |
| 2762- | BetA, | Targeting Effect of Betulinic Acid Liposome Modified by Hyaluronic Acid on Hepatoma Cells In Vitro |
| - | in-vitro, | Liver, | HepG2 |
| 2748- | BetA, | Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy |
| - | Review, | Var, | NA |
| 3989- | betaCar, | Dietary factors that affect the bioavailability of carotenoids |
| 5597- | Bical, | Bicalutamide: clinical pharmacokinetics and metabolism |
| - | Review, | Pca, | NA |
| 5473- | BM, | Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability |
| - | in-vivo, | AD, | NA | - | in-vivo, | Park, | NA |
| 5649- | BNL, | Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability |
| - | Review, | Nor, | NA |
| 5654- | BNL, | Pharmacokinetics of natural borneol after oral administration in mice brain and its effect on excitation ratio |
| - | in-vivo, | Nor, | NA |
| 5655- | BNL, | Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations |
| - | in-vivo, | Nor, | NA |
| 5660- | BNL, | Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System |
| - | Review, | Var, | NA |
| 5663- | BNL, | Osthole/borneol thermosensitive gel via intranasal administration enhances intracerebral bioavailability to improve cognitive impairment in APP/PS1 transgenic mice |
| - | in-vivo, | AD, | NA |
| 5664- | BNL, | Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration |
| - | in-vivo, | Nor, | NA |
| 5666- | BNL, | Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider |
| - | in-vivo, | AD, | NA |
| 5668- | BNL, | Anticancer effect of borneol: Mechanistic insights through literature review and in silico studies |
| - | Review, | Var, | NA |
| 3504- | Bor, | Boron Contents of German Mineral and Medicinal Waters and Their Bioavailability in Drosophila melanogaster and Humans |
| - | Review, | NA, | NA |
| 758- | Bor, | Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines |
| - | Human, | NA, | NA |
| 764- | Bor, | Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells |
| - | in-vitro, | Liver, | HepG2 |
| 3867- | Bos, | Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers |
| - | Human, | Nor, | NA |
| 3868- | Bos, | Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(®)) of Boswellia extract |
| 2767- | Bos, | The potential role of boswellic acids in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2772- | Bos, | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
| - | Review, | AD, | NA |
| 1419- | Bos, | Enhanced Bioavailability of Boswellic Acid by Piper longum: A Computational and Pharmacokinetic Study |
| - | in-vivo, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid